7 May 2026
She presented the only biotechnology platform revolutionizing sun protection through bioadhesive UV filters
Skinosive, represented by Agnes Menut, Business Development Director, has presented the only biotechnology platform revolutionizing sun protection through bioadhesive UV filters, at the Skin Excellence Annual Meeting 2026 ☀️
The event also provided an opportunity to meet and discuss with key industry players about the potential of our platform and the company’s future outlook, which confirms the strong interest in our technology and the need to generate safe and long-lasting bioadhesive UV filters. 🔬
Thank you to Eurobiomed for the invitation and for organizing this conference, which brings together leaders in the sun protection industry like Eric Ducournau, CEO of Laboratoires Pierre Fabre.
Skin excellence is a merge of prevention, treatment and research on Skin disease, a merge of industrial (dermocosmetics, pharmaceuticals) and academics, hospital.
As a reminder, Skinosive, founded by Truffle Capital, is a dermocosmetic biotechnology company that is transforming sun protection with safe and long-lasting bioadhesive UV filters.
